Difference between revisions of "Team:CSMU Taiwan/Demonstrate"

Line 3: Line 3:
 
<html>
 
<html>
 
<style>
 
<style>
−
ol li {
+
    ol li {
 
     font-size: 17px;
 
     font-size: 17px;
 
}
 
}
Line 11: Line 11:
 
}
 
}
 
</style>
 
</style>
 +
 
<body class="" data-spy="scroll" data-target="#myScrollspy" style="background-color:#353535;">
 
<body class="" data-spy="scroll" data-target="#myScrollspy" style="background-color:#353535;">
 
     <a class="anchorOffset" id="start"></a>
 
     <a class="anchorOffset" id="start"></a>
 
     <!--------- NAVBAR-------------------------------------------------------------------------------------------------------------------------------------------------------------->
 
     <!--------- NAVBAR-------------------------------------------------------------------------------------------------------------------------------------------------------------->
 
     <!------------CONTENEDOR PRINCIPAL ---------------------------------------------------------------------------------------------------------------------------------->
 
     <!------------CONTENEDOR PRINCIPAL ---------------------------------------------------------------------------------------------------------------------------------->
−
  <div class="main-container">
+
    <div class="main-container">
−
    <section style="background-size: 100%;height: 95% ;margin-top: 0em;padding-top: 1.1em;" class="height-90 parallax">
+
        <section style="background-size: 100%;height: 95% ;margin-top: 0em;padding-top: 1.1em;" class="height-90 parallax">
−
        <div class="main-container" style="height: 100%;">
+
            <div class="main-container" style="height: 100%;">
−
            <center style="height: 100%;">
+
                <center style="height: 100%;">
−
                <div class="col-md-12" style="height: 100%;margin-top:2em; padding:0px">
+
                    <div class="col-md-12" style="height: 100%;margin-top:2em; padding:0px">
−
                    <div id="logoPrinteria" class="item" style="background-image: url(https://static.igem.org/mediawiki/2019/c/c5/T--CSMU_Taiwan--cover_project.png);height: 100%;    width: 100%;background-attachment: fixed;background-size: cover;">
+
                        <div id="logoPrinteria" class="item" style="background-image: url(https://static.igem.org/mediawiki/2019/c/c5/T--CSMU_Taiwan--cover_project.png);height: 100%;    width: 100%;background-attachment: fixed;background-size: cover;">
−
                        <img src="https://static.igem.org/mediawiki/2019/4/4d/T--CSMU_Taiwan--demonstrate.png" style=" margin-top: 0px;">
+
                            <img src="https://static.igem.org/mediawiki/2019/4/4d/T--CSMU_Taiwan--demonstrate.png" style=" margin-top: 0px;">
−
                       
+
                            </a>
−
                         </a>
+
                         </div>
 
                     </div>
 
                     </div>
−
                 </div>
+
                 </center>
−
             </center>
+
             </div>
−
         </div>
+
         </section>
−
      </section>
+
−
                       
+
 
     </div>
 
     </div>
 
     <a class="anchorOffset" id="story"></a>
 
     <a class="anchorOffset" id="story"></a>
Line 54: Line 53:
 
                                 </div>
 
                                 </div>
 
                             </li>
 
                             </li>
−
                         
 
 
                         </ul>
 
                         </ul>
 
                         <ul class="tabs-content">
 
                         <ul class="tabs-content">
Line 64: Line 62:
 
                         <a class="anchorOffset" id="A" tabindex="-1" style="outline: none;"></a>
 
                         <a class="anchorOffset" id="A" tabindex="-1" style="outline: none;"></a>
 
                         <h2>Overview</h2>
 
                         <h2>Overview</h2>
−
<p>In addition to comply to all rules and policies approved by the iGEM Safety Committee (please see our Safety page), we self-evaluate the safety of our project with the <b>Risk Mitigation Plan</b> referring the selective agent and dual use research management regulations of TCDC. </p>
+
                        <p>In addition to comply to all rules and policies approved by the iGEM Safety Committee (please see our Safety page), we self-evaluate the safety of our project with the <b>Risk Mitigation Plan</b> referring the selective agent and dual use research management regulations of TCDC. </p>
−
 
+
                        <div class="pdf-area">
−
  <div class="pdf-area">
+
                            <span class="pdfbtn" id="notebook-btn-1">Risk mitigation plan</i></span>
−
                                    <span class="pdfbtn" id="notebook-btn-1">Risk mitigation plan</i></span>
+
                            <div class="img-container" id="notebook-1">
−
                                    <div class="img-container" id="notebook-1">
+
                                <embed src="https://static.igem.org/mediawiki/2019/a/a9/T--CSMU_Taiwan--safetypdf1.pdf" style="width:100%; height:850px" frameborder="0"></embed>
−
                                        <embed src="https://static.igem.org/mediawiki/2019/a/a9/T--CSMU_Taiwan--safetypdf1.pdf" style="width:100%; height:850px" frameborder="0"></embed>
+
                            </div>
−
                                    </div>
+
−
                               
+
−
</div>
+
−
<p>This year, we design an aptamer-type rapid diagnostic kit called influsensor, trying to solve the disadvantages of screening on the influenza nowadays. (please see our Description page) </p>
+
−
 
+
−
<p>There are two main products in our project: </p>
+
−
<ol>
+
−
<li> The aptamer with high affinity and specificity designed for rapid diagnostic test</li>
+
−
<li> Influensor (aptamer-type rapid diagnostic kit) that is extremely easy for doctors to use</li>
+
−
</ol>
+
−
<p>Overall, our the aptamers selected out by the target proteins NPA and HA3 have been proved to possess the properties of high affinity and specificity through our experiments, indicateing that there is a potential to replacing the current antibody-type rapid influenza diagnostic strip. (please see our Entrepreneurship page) </p>
+
−
 
+
−
<h2>Aptamers<h2>
+
−
<p>This year, we acquire four successful experimental results related to produce aptamers with high affinity and specificity in our project: </p>
+
−
<h3>Target protein with optimized sequence<h3>
+
−
<div class="fig">
+
−
                <img src="https://static.igem.org/mediawiki/2019/f/f7/T--CSMU_Taiwan--result4.png" style="margin-top: 0px;">
+
−
            </div>
+
−
<div class="fig">
+
−
                <img src="https://static.igem.org/mediawiki/2019/e/e5/T--CSMU_Taiwan--result5.png" style="margin-top: 0px;">
+
−
            </div>
+
−
<h3>SELEX</h3>
+
−
 
+
−
<h3>ELISA</h3>
+
−
 
+
−
<h3>Rapid diagnostic test strip</h3>
+
−
 
+
−
<p>(Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Results">Results</a> page)</p>
+
−
<h2>Influsensor</h2>
+
−
<p><嵌入 strip, casing, swab照片, 收合></p>
+
−
<p>Influsensor is an aptamer-type rapid diagnostic kit with the characteristics of <b>low cost, fast production and development, high stability, low false-negative rate</b>, and <b>animal free</b>. (Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
+
−
 
+
−
<p>Influsensor is made of aptamer-type rapid diagnostic strip, casing, and swab. We design every component of the kit with ingenuity. We also demonstrate the user manual and the video of user guide. All of our designs are aim for making doctors manipulate the kit easily. (Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
+
−
.
+
−
<p>Because of all the advantages and features of the aptamer, we integrate all the benefits of atpamers and design a model containing all the aspects of a disease: Rapid screening, Prediction, Prevention, and Treatment.
+
−
The model is called <b>CSMU_Taiwan Influsystem</b>. </p>
+
−
<div style="border: solid 1px; border-radius:5px;padding: 0 13px; margin-bottom:5px;">
+
−
<p><b>CSMU_Taiwan Influsystem</b></p>
+
−
 
+
−
<p>Rapid screening- Aptamer-type rapid diagnostic strip (Influsensor) </p>
+
−
<p>Prediction- AI system </p>
+
−
<p>Prevention- Air purifier </p>
+
−
<p>Treatment- Anti-hemagglutinin drug</p>
+
−
</div>
+
−
<p>(Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Description "> Description</a> page and <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
+
−
 
+
−
 
+
 
                         </div>
 
                         </div>
 +
                        <p>This year, we design an aptamer-type rapid diagnostic kit called influsensor, trying to solve the disadvantages of screening on the influenza nowadays. (please see our Description page) </p>
 +
                        <p>There are two main products in our project: </p>
 +
                        <ol>
 +
                            <li> The aptamer with high affinity and specificity designed for rapid diagnostic test</li>
 +
                            <li> Influensor (aptamer-type rapid diagnostic kit) that is extremely easy for doctors to use</li>
 +
                        </ol>
 +
                        <p>Overall, our the aptamers selected out by the target proteins NPA and HA3 have been proved to possess the properties of high affinity and specificity through our experiments, indicateing that there is a potential to replacing the current antibody-type rapid influenza diagnostic strip. (please see our Entrepreneurship page) </p>
 +
                        <h2>Aptamers</h2>
 +
                        <p>This year, we acquire four successful experimental results related to produce aptamers with high affinity and specificity in our project: </p>
 +
                        <h3>Target protein with optimized sequence</h3>
 +
                        <div class="fig">
 +
                            <img src="https://static.igem.org/mediawiki/2019/f/f7/T--CSMU_Taiwan--result4.png" style="margin-top: 0px;">
 +
                        </div>
 +
                        <div class="fig">
 +
                            <img src="https://static.igem.org/mediawiki/2019/e/e5/T--CSMU_Taiwan--result5.png" style="margin-top: 0px;">
 +
                        </div>
 +
                        <h3>SELEX</h3>
 +
                        <h3>ELISA</h3>
 +
                        <h3>Rapid diagnostic test strip</h3>
 +
                        <p>(Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Results">Results</a> page)</p>
 +
                        <h2>Influsensor</h2>
 +
                        <p>
 +
                            <嵌入 strip, casing, swab照片, 收合>
 +
                        </p>
 +
                        <p>Influsensor is an aptamer-type rapid diagnostic kit with the characteristics of <b>low cost, fast production and development, high stability, low false-negative rate</b>, and <b>animal free</b>. (Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
 +
                        <p>Influsensor is made of aptamer-type rapid diagnostic strip, casing, and swab. We design every component of the kit with ingenuity. We also demonstrate the user manual and the video of user guide. All of our designs are aim for making doctors manipulate the kit easily. (Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
 +
                        .
 +
                        <p>Because of all the advantages and features of the aptamer, we integrate all the benefits of atpamers and design a model containing all the aspects of a disease: Rapid screening, Prediction, Prevention, and Treatment.
 +
                            The model is called <b>CSMU_Taiwan Influsystem</b>. </p>
 +
                        <div style="border: solid 1px; border-radius:5px;padding: 0 13px; margin-bottom:5px;">
 +
                            <p><b>CSMU_Taiwan Influsystem</b></p>
 +
                            <p>Rapid screening- Aptamer-type rapid diagnostic strip (Influsensor) </p>
 +
                            <p>Prediction- AI system </p>
 +
                            <p>Prevention- Air purifier </p>
 +
                            <p>Treatment- Anti-hemagglutinin drug</p>
 +
                        </div>
 +
                        <p>(Please see our <a href="https://2019.igem.org/Team:CSMU_Taiwan/Description "> Description</a> page and <a href="https://2019.igem.org/Team:CSMU_Taiwan/Design">Design</a> page)</p>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 128: Line 116:
 
     </a>
 
     </a>
 
     <script type="text/javascript">
 
     <script type="text/javascript">
−
$(document).ready(function() {
+
    $(document).ready(function() {
  
−
    for (var i = 1; i < 50; i++) {
+
        for (var i = 1; i < 50; i++) {
−
        $('#notebook-btn-' + i).click(toggleContainer(i));
+
            $('#notebook-btn-' + i).click(toggleContainer(i));
−
    }
+
        }
 +
 
 +
        $('.top').on('click', function() {
 +
            $('html, body').animate({ scrollTop: '0px' }, 500);
 +
        });
  
−
    $('.top').on('click', function() {
 
−
        $('html, body').animate({ scrollTop: '0px' }, 500);
 
 
     });
 
     });
−
 
+
    $(function() {
−
});       
+
        removeSection = function(e) {
−
  $(function(){
+
            $(e).parents(".section").remove();
−
      removeSection = function(e) {
+
            $('[data-spy="scroll"]').each(function() {
−
        $(e).parents(".section").remove();
+
                var $spy = $(this).scrollspy('refresh')
−
        $('[data-spy="scroll"]').each(function () {
+
−
            var $spy = $(this).scrollspy('refresh')
+
 
             });
 
             });
−
      }
+
        }
−
      $("#myScrollspy").scrollspy();
+
        $("#myScrollspy").scrollspy();
−
    });
+
−
 
+
−
$(document).ready(function() {
+
−
 
+
−
    for (var i = 1; i < 50; i++) {
+
−
        $('#notebook-btn-' + i).click(toggleContainer(i));
+
−
    }
+
−
 
+
−
    $('.top').on('click', function() {
+
−
        $('html, body').animate({ scrollTop: '0px' }, 500);
+
 
     });
 
     });
  
−
});
+
    function toggleContainer(i) {
−
 
+
        return function() {
−
function toggleContainer(i) {
+
            if ($('#notebook-' + i).is(":visible")) {
−
    return function() {
+
                $('#notebook-' + i).slideToggle(500);
−
        if ($('#notebook-' + i).is(":visible")) {
+
            } else {
−
            $('#notebook-' + i).slideToggle(500);
+
                $('.img-container:visible').slideToggle(500);
−
        } else {
+
                $('#notebook-' + i).slideToggle(500);
−
            $('.img-container:visible').slideToggle(500);
+
            }
−
            $('#notebook-' + i).slideToggle(500);
+
            $('.bg-container').css('max-height', '280vh')
 +
            $('.main-content').css('min-height', '200vh')
 
         }
 
         }
−
        $('.bg-container').css('max-height', '280vh')
 
−
        $('.main-content').css('min-height', '200vh')
 
 
     }
 
     }
−
} 
+
    </script>
−
 
+
−
</script>
+
−
 
+
 
</body>
 
</body>
−
 
  
 
</html>
 
</html>
 
{{CSMU Taiwan/footer}}
 
{{CSMU Taiwan/footer}}

Revision as of 16:54, 21 October 2019

Stack Multipurpose HTML Template

Overview

In addition to comply to all rules and policies approved by the iGEM Safety Committee (please see our Safety page), we self-evaluate the safety of our project with the Risk Mitigation Plan referring the selective agent and dual use research management regulations of TCDC.

Risk mitigation plan

This year, we design an aptamer-type rapid diagnostic kit called influsensor, trying to solve the disadvantages of screening on the influenza nowadays. (please see our Description page)

There are two main products in our project:

  1. The aptamer with high affinity and specificity designed for rapid diagnostic test
  2. Influensor (aptamer-type rapid diagnostic kit) that is extremely easy for doctors to use

Overall, our the aptamers selected out by the target proteins NPA and HA3 have been proved to possess the properties of high affinity and specificity through our experiments, indicateing that there is a potential to replacing the current antibody-type rapid influenza diagnostic strip. (please see our Entrepreneurship page)

Aptamers

This year, we acquire four successful experimental results related to produce aptamers with high affinity and specificity in our project:

Target protein with optimized sequence

SELEX

ELISA

Rapid diagnostic test strip

(Please see our Results page)

Influsensor

<嵌入 strip, casing, swab照片, 收合>

Influsensor is an aptamer-type rapid diagnostic kit with the characteristics of low cost, fast production and development, high stability, low false-negative rate, and animal free. (Please see our Design page)

Influsensor is made of aptamer-type rapid diagnostic strip, casing, and swab. We design every component of the kit with ingenuity. We also demonstrate the user manual and the video of user guide. All of our designs are aim for making doctors manipulate the kit easily. (Please see our Design page)

.

Because of all the advantages and features of the aptamer, we integrate all the benefits of atpamers and design a model containing all the aspects of a disease: Rapid screening, Prediction, Prevention, and Treatment. The model is called CSMU_Taiwan Influsystem.

CSMU_Taiwan Influsystem

Rapid screening- Aptamer-type rapid diagnostic strip (Influsensor)

Prediction- AI system

Prevention- Air purifier

Treatment- Anti-hemagglutinin drug

(Please see our Description page and Design page)